Femasys (FEMY) Current Assets (2020 - 2026)
Femasys' (FEMY) quarterly Current Assets came in at $8.3 million in Q2 2026, down 14.55% on a YoY basis from $9.8 million in Q2 2025, and down 32.5% quarter-over-quarter from $12.3 million in Q1 2026.
Analysis
Femasys (FEMY) Current Assets (2020 - 2026) Analysis & Trends
Femasys (FEMY) has reported Current Assets for 7 consecutive years, with $8.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Current Assets fell 14.55% year-over-year to $8.3 million; the trailing twelve-month figure through Jun 2026 stood at $8.3 million (down 14.55% YoY), and the FY2025 full-year result was $16.5 million, up 105.13% from the prior year.
- Current Assets declined to $8.3 million in Q2 2026 per FEMY's latest filing, from $12.3 million in the prior quarter.
- Across five years, Current Assets topped out at $23.2 million in Q4 2023 and bottomed at $8.0 million in Q4 2024.
- Historically, Current Assets has averaged $14.1 million across 5 years, with a median of $12.3 million in 2025.
- The sharpest annual moves came in 2024 and 2025: Current Assets sank 65.39% in 2024, then soared 105.13% in 2025.
- Over 5 years, Current Assets stood at $14.1 million in 2022, then surged by 64.02% to $23.2 million in 2023, then tumbled by 65.39% to $8.0 million in 2024, then soared by 105.13% to $16.5 million in 2025, then tumbled by 49.37% to $8.3 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $8.3 million, $12.3 million, and $16.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 24.52 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 9.54 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 24.39 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 14.42 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 7.97 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 6.82 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 6.62 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 4.09 Bn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 2.45 Bn |
| 10 | Femasys | 9.01 Mn | 7.57 Mn | 189,391.00 | 8.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.33 Mn |
| Mar 31, 2026 | 12.34 Mn |
| Dec 31, 2025 | 16.46 Mn |
| Sep 30, 2025 | 12.25 Mn |
| Jun 30, 2025 | 9.75 Mn |
| Mar 31, 2025 | 9.13 Mn |
| Dec 31, 2024 | 8.02 Mn |
| Sep 30, 2024 | 11.30 Mn |
| Jun 30, 2024 | 15.93 Mn |
| Mar 31, 2024 | 19.88 Mn |
| Dec 31, 2023 | 23.18 Mn |
| Sep 30, 2023 | 10.23 Mn |
| Jun 30, 2023 | 12.03 Mn |
| Mar 31, 2023 | 11.33 Mn |
| Dec 31, 2022 | 14.13 Mn |
| Sep 30, 2022 | 17.29 Mn |
| Jun 30, 2022 | 20.33 Mn |
| Mar 31, 2022 | 22.73 Mn |
| Dec 31, 2021 | 25.63 Mn |
| Sep 30, 2021 | 28.33 Mn |